MWM
ACER

Meridian Wealth Management’s Acer Therapeutics Inc ACER Stock Holding History

Meridian Wealth Management’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-106,250
Closed -$80.6K – 569
2023
Q1 		$80.6K Buy
106,250
+34,500
+48% +$68.1K 0.01% 533
2022
Q4 		$180K Buy
+71,750
New +$123K 0.02% 493

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meridian Wealth Management's ACER Position: Q2 2023 in Review

Meridian Wealth Management sold out of Acer Therapeutics Inc (ACER) in Q2 2023, closing a stake of 106,250 shares — an estimated $80.6K sold.

Meridian Wealth Management first reported a position in ACER in Q4 2022 and held it in 2 quarters. The position peaked at $180K in Q4 2022. 28 funds tracked by Wall St. Rank hold ACER as of Q2 2023.

  • Meridian Wealth Management reported no remaining Acer Therapeutics Inc position as of Q2 2023 after selling out during the quarter.
  • Meridian Wealth Management sold 106,250 Acer Therapeutics Inc shares in Q2 2023, an estimated $80.6K.
  • Meridian Wealth Management first reported a position in Acer Therapeutics Inc in Q4 2022 and held it in 2 quarters.
  • Meridian Wealth Management's Acer Therapeutics Inc position peaked at $180K in Q4 2022.
  • 28 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2023.

Based on Meridian Wealth Management's 13F filing for Q2 2023, filed 2 Aug 2023.